Monopar Therapeutics MNPR Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax at other companies
Other financials
Where this comes from
Reported directly by Monopar Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax.
The official record: Monopar Therapeutics’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax?
- Monopar Therapeutics (MNPR) reported other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax of -$190 in Q1 2026.
- How has Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax changed year-over-year?
- Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax decreased by 115.3% year-over-year, from $1.24K to -$190.
- What is the long-term trend for Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax?
- Over 3 years (2021 to 2025), Monopar Therapeutics's other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax has grown at a -18.4% compound annual growth rate (CAGR), from $4.72K to -$2.56K.
- What does other comprehensive income foreign currency transaction and translation gain loss arising during period net of tax mean?
- This metric captures the net gains or losses resulting from the translation of financial statements from foreign subsidiaries or transactions denominated in currencies other than the company's functional currency. It reflects the impact of exchange rate fluctuations on the company's equity position without affecting immediate cash flow. For a clinical-stage firm, this highlights exposure to international market volatility.